Skip to main content

Pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs

Summary

The pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs were investigated. Blood concentrations of acyclovir were determined by RP-HPLC after a single oral dose of two kinds of acyclovir tablets given separately to 6 beagle dogs. The main pharmacokinetics parameters of the acyclovir sustained-release tablet were as follows: T1/2, Tmax and Cmax were 4.10±0.20 h, 4.05±0.54 h and 6.90±0.68 μg-ml−1, respectively. MRT was 9.02±0.44 h. Using acyclovir standard tablet as control, relative bioavailability of the acyclovir sustained-release tablet was 152.2±49.90 %. According to the two-tailed f-test, there was a distinct difference in the data for Tmax, Cmax and AUC between acyclovir sustained-release tablets and acyclovir standard tablets, and the absorbability of acyclovir sustained-release tablets was much better than that of the acyclovir standard tablets.

This is a preview of subscription content, access via your institution.

References

  1. Guo Y.M., Zhang C.X., Zhang L. (1994): Pharmacokinetics of acyclovir capsule in vivo in humans by reversed-phase high performance liquid chromatography, China Hosp. Med. J., 14,437–438.

    Google Scholar 

  2. Huang G.H., Deng S.H., Wang F. (2001): Study of the bioavailability of acyclovir in humans. J. Shenyang Pharm. Univ., 18,260–263.

    CAS  Google Scholar 

  3. He L., Zhu H., Jiang X.H. (1998): Pharmacokinetics and bioavailability of two kinds of acyclovir tablet. China Clin. Med. J., 7,275–278.

    Google Scholar 

  4. Zhang D., Chen J., Wang C.Q. (2001): Pharmacokinetics of sustained capsule of acyclovir after single and multiple oral doses in dogs. Huaxi Med. J, 17(2): 101–103.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yang, Q., Hu, Q. Pharmacokinetics and bioavailability of acyclovir sustained-release tablets in dogs. European Journal of Drug Metabolism and Pharmacokinetics 31, 17–20 (2006). https://doi.org/10.1007/BF03190637

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190637

Keywords

  • Acyclovir
  • pharmacokinetics
  • bioavailability
  • HPLC